Latest News and Press Releases
Want to stay updated on the latest news?
-
Phase 1 Clinical Data Demonstrate Dose-Proportional PK, No Dose-Limiting Toxicities Through Four Dose Levels, and Concordance with Preclinical PBPK Predictions CRANBERRY TOWNSHIP, Pa., May 11, 2026 ...
-
Jabez Biosciences Announces Opening of Second Clinical Site in Phase 1 study in Solid Tumors and NHL